As advanced therapies continue to transform the healthcare landscape, the need for sustainable manufacturing solutions grows more critical. Traditional plasmid DNA (pDNA) production presents costly, resource-intensive challenges, threatening scalability and accessibility in gene and cell therapies. Touchlight’s innovative dbDNA™ technology offers an enzymatic alternative that’s efficient, scalable, and environmentally sustainable.

This article explores how dbDNA™ is reshaping DNA manufacturing and setting new sustainability standards by reducing water use, eliminating bacterial impurities, and minimizing waste. Learn how this pioneering approach unlocks a more sustainable future for genetic medicine.

What You’ll Learn:

• The impact of traditional pDNA production on environmental sustainability
• How dbDNA™ enables more efficient, scalable, and environmentally friendly manufacturing
• Why sustainable DNA production is vital to advancing gene and cell therapies